share_log

HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52

HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52

HC Wainwright公司继续买入anaptysbio股票,将目标价调低至$52
Benzinga ·  11/06 13:45  · 评级/大行评级

HC Wainwright & Co. analyst Emily Bodnar maintains AnaptysBio (NASDAQ:ANAB) with a Buy and lowers the price target from $55 to $52.

HC Wainwright & Co. 分析师艾米丽·博德纳尔维持AnaptysBio(纳斯达克股票代码:ANAB)的买入并将目标股价从55美元下调至52美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发